Association between serum uric acid levels and coronary flow reserve in hypertensive patients without concomitant risk factors

被引:10
作者
Caliskan, Mustafa
Erdogan, Dogan
Gullu, Hakan
Yildirim, Ibrahim
Ozer, Ismail
Yildirir, Aylin
Muderrisoglu, Haldun
机构
[1] Baskent Univ, Fac Med, Dept Cardiol, TR-06490 Ankara, Turkey
[2] Suleyman Demirel Univ, Fac Med, Dept Cardiol, Isparta, Turkey
[3] Baskent Univ, Fac Med, Dept Internal Med, Div Nephrol, TR-06490 Ankara, Turkey
关键词
coronary flow reserve; echocardiography; hypertension; target-organ damage; uric acid; 2ND-HARMONIC ECHO-DOPPLER; HEART-DISEASE; CARDIOVASCULAR-DISEASE; ARTERIAL-HYPERTENSION; HYPERURICEMIA; MORTALITY; ECHOCARDIOGRAPHY; DYSFUNCTION; IMPAIRMENT; MECHANISM;
D O I
10.1080/08037050701428240
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Background. Hyperuricemia is associated with hypertension, vascular disease and cardiovascular (CV) disease. However, the role of serum uric acid (SUA) level as an independent risk factor for CV and renal morbidity in hypertension remains controversial. Accordingly, we aimed to determine whether SUA levels are independently and specifically associated with coronary flow reserve (CFR) impairment in hypertensive patients. Methods. We examined 80 never treated and newly diagnosed hypertensive individuals. The hypertensive individuals were divided into two groups based on CFR values. Results. Subjects with altered CFR (v2) had significantly higher SUA levels compared with those with normal CFR (>= 2) (346.0 +/- 98.1 vs 260.7 +/- 75.6 mu mo1/1, p<0.0001). After adjusting for potential confounders, including age, sex, body mass index, blood pressure, lipids and creatinine, we found that SUA levels were independently associated with CFR impairment (beta=-20.417, p < 0.0001). We also found that SUA levels were a good predictor of low CFR at the receiver- operating characteristic curve. Area under the curve was 76% (95% CI 0.64 - 0.88), and SUA levels were significantly predictive of low CFR (p < 0.0001). Conclusions. These results support a role for SUA level as an independent marker of target organ damage in hypertension.
引用
收藏
页码:254 / 261
页数:8
相关论文
共 38 条
[1]   Uric acid and cardiovascular risk [J].
Alderman, MH .
CURRENT OPINION IN PHARMACOLOGY, 2002, 2 (02) :126-130
[2]   Serum uric acid and cardiovascular events in successfully treated hypertensive patients [J].
Alderman, MH ;
Cohen, H ;
Madhavan, S ;
Kivlighn, S .
HYPERTENSION, 1999, 34 (01) :144-150
[3]   HYPERURICEMIA AS A RISK FACTOR OF CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY [J].
BRAND, FN ;
MCGEE, DL ;
KANNEL, WB ;
STOKES, J ;
CASTELLI, WP .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 1985, 121 (01) :11-18
[4]   IMPAIRED DIASTOLIC FUNCTION AND CORONARY RESERVE IN GENETIC-HYPERTENSION - ROLE OF INTERSTITIAL FIBROSIS AND MEDIAL THICKENING OF INTRAMYOCARDIAL CORONARY-ARTERIES [J].
BRILLA, CG ;
JANICKI, JS ;
WEBER, KT .
CIRCULATION RESEARCH, 1991, 69 (01) :107-115
[5]   Contrast-enhanced transthoracic second harmonic echo Doppler with adenosine - A noninvasive, rapid and effective method for coronary flow reserve assessment [J].
Caiati, C ;
Zedda, N ;
Montaldo, C ;
Montisci, R ;
Iliceto, S .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (01) :122-130
[6]   New noninvasive method for coronary flow reserve assessment - Contrast-enhanced transthoracic second harmonic echo Doppler [J].
Caiati, C ;
Montaldo, C ;
Zedda, N ;
Bina, A ;
Iliceto, S .
CIRCULATION, 1999, 99 (06) :771-778
[7]  
Campion E W, 1987, Am J Med, V82, P421, DOI 10.1016/0002-9343(87)90441-4
[8]   ECHOCARDIOGRAPHIC DETERMINATION OF LEFT-VENTRICULAR MASS IN MAN - ANATOMIC VALIDATION OF METHOD [J].
DEVEREUX, RB ;
REICHEK, N .
CIRCULATION, 1977, 55 (04) :613-618
[9]   Relationship of serum uric acid to measures of endothelial function and atherosclerosis in healthy adults [J].
Erdogan, D ;
Gullu, H ;
Caliskan, M ;
Yildirim, E ;
Bilgi, M ;
Ulus, T ;
Sezgin, N ;
Muderrisoglu, H .
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2005, 59 (11) :1276-1282
[10]   Coronary flow reserve in dipper and non-dipper hypertensive patients [J].
Erdogan, D ;
Gullu, H ;
Caliskan, M ;
Yildirim, I ;
Ulus, T ;
Bilgi, M ;
Muderrisoglu, H .
BLOOD PRESSURE, 2005, 14 (06) :345-352